On this page
RXYLT1
ribitol xylosyltransferase 1
RXYLT1 is located on the long (q) arm of chromosome 12, at band 12q14.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 12 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The RXYLT1 gene, located on chromosome 12, encodes ribitol xylosyltransferase 1, an enzyme that participates in protein glycosylation. Glycosylation refers to the chemical addition of sugar groups to proteins, a process essential for proper protein folding, stability, and cellular signalling. The RXYLT1 enzyme specifically transfers xylose residues onto ribitol groups already attached to target proteins.
This specialised enzymatic activity contributes to the modification of certain proteoglycans and glycoproteins. Whilst RXYLT1 represents a relatively recently characterised member of the glycosyltransferase family, research into its biological roles continues to develop. Understanding the function of RXYLT1 helps clarify how cells regulate protein quality and maintain normal tissue architecture.
What the gene does
Ribitol xylosyltransferase 1 functions as a glycosyltransferase, an enzyme class responsible for transferring sugar moieties from activated donor molecules to acceptor substrates. Specifically, RXYLT1 catalyses the transfer of xylose from UDP-xylose onto ribitol phosphate chains that have already been attached to serine residues on target proteins. This activity represents one step in a multi-enzyme pathway that builds complex glycan structures on proteoglycans.
The glycosylation modifications performed by RXYLT1 influence how proteins interact with other molecules in the extracellular matrix and on cell surfaces. Proper glycosylation helps maintain the structural integrity of connective tissues and may affect cellular adhesion and signalling pathways. The enzyme operates within the endoplasmic reticulum and Golgi apparatus, cellular compartments where most protein glycosylation occurs.
By contributing to glycan assembly, RXYLT1 supports the maturation of proteoglycans that play roles in tissue development and maintenance. The precise substrate specificity and regulation of RXYLT1 activity remain areas of active investigation in glycobiology research.
Video: Genetics 101
Chromosome location
The RXYLT1 gene resides on the long arm of chromosome 12 at cytogenetic band 12q14.2. This chromosomal region contains numerous genes involved in diverse cellular processes. The genomic structure of RXYLT1, including the number and arrangement of exons that comprise the coding sequence, has not been fully detailed in public databases. Understanding the genomic organisation of RXYLT1 can inform investigations into regulatory elements that control when and where the gene is expressed across different tissues.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. The overall length of the RXYLT1 protein has not been definitively established in current reference databases. Like other glycosyltransferases, the protein likely contains a catalytic domain responsible for binding the sugar donor and acceptor substrates, though the precise boundaries and structural features of functional regions await comprehensive biochemical and structural studies.
Key variants
Genetic variants in RXYLT1 may affect the enzyme's activity, stability, or expression levels. Changes in the DNA sequence can range from single nucleotide substitutions to larger deletions or insertions. Some variants may alter amino acids critical for enzymatic function, whilst others might influence how efficiently the gene is transcribed into messenger RNA. The clinical significance of most RXYLT1 variants remains uncertain, reflecting the ongoing process of correlating genetic changes with observable effects on health.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Research into the clinical consequences of RXYLT1 variants is still emerging. Alterations in genes involved in glycosylation pathways can sometimes lead to congenital disorders of glycosylation, a group of inherited conditions affecting multiple organ systems. Whether RXYLT1 variants contribute to such disorders or other specific health conditions requires further study. As the scientific understanding of RXYLT1 biology advances, clearer associations between genetic changes and clinical phenotypes may be identified.
No disease links recorded for this gene in our reference set.
UK clinical status
Frequently asked questions
What does the RXYLT1 gene do?
RXYLT1 provides instructions for making an enzyme that adds xylose sugar molecules to ribitol groups on certain proteins, a process important for proper protein modification and function.
Where is the RXYLT1 gene located?
The RXYLT1 gene is located on chromosome 12 at position 12q14.2, on the long arm of the chromosome.
Are there clinical tests available for RXYLT1?
RXYLT1 is not currently included in NHS genomic testing panels, reflecting the early stage of research into its clinical significance. Genetic testing availability may change as understanding of this gene develops.